Author Question: To stabilize a patient during the initial application of ventilatory support, which of the following ... (Read 24 times)

Pea0909berry

  • Hero Member
  • *****
  • Posts: 573
To stabilize a patient during the initial application of ventilatory support, which of the following parameters must be set? 1. Airway temperature 2. Ventilatory support mode 3. O2 concentration (FiO2) 4. Minute ventilation (f, VT)
 
  a. 1 and 3 only
  b. 1, 2, and 3 only
  c. 2, 3, and 4 only
  d. 1, 2, 3, and 4

Question 2

Which of the following is an advantage of Pressure Control Ventilation?
 
  a. Higher mean airway pressure can decrease venous return.
  b. VT varies depending on lung compliance, resistance, and patient effort.
  c. Improved gas distribution allows for lower VT.
  d. If VT or minute ventilation alarms are not set properly, alveolar hypoventilation and acidosis may not be detected.



nikmaaacs

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

ANS: B
Box 48-3 summarizes key decisions that must be made as a part of initial ventilator setup.

Answer to Question 2

ANS: C
Box 48-5 summarizes the Advantages and Disadvantages of Pressure Control Ventialtion.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library